Skip to content

Aura Biosciences, Inc. AURA Other Non Cash Items

Other Non Cash Items at other companies

Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$82K+1,267%
Aflac logo
AflacAFL
$664M+109%
Oceaneering International logo
Oceaneering InternationalOII
$318.75K-46.2%
Energy Transfer logo
Energy TransferET
$11M+179%
Brookfield Asset Management logo
Brookfield Asset ManagementBAM
$34M+478%
Apollo Global Management logo
Apollo Global ManagementAPO
$163M+154%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept aura:OtherNonCashItems.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s other non cash items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s other non cash items?
Aura Biosciences, Inc. (AURA) reported other non cash items of $0 in Q1 2026.
How has Aura Biosciences, Inc.'s other non cash items changed year-over-year?
Aura Biosciences, Inc.'s other non cash items decreased by 100.0% year-over-year, from $27K to $0.
What does other non cash items mean?
Represents miscellaneous non-cash adjustments to net income that do not involve the physical movement of cash. These items are added back or subtracted from net income to reconcile to net cash provided by operating activities. This metric helps investors identify non-recurring or secondary accounting adjustments that impact reported earnings but not liquidity.